Cutaneous Manifestation of Paroxysmal Nocturnal Hemoglobinuria
DOI:
https://doi.org/10.24950/rspmi.2778Keywords:
Eculizumab, Hemoglobinuria, Paroxysmal/diagnosis, Hemoglobinuria, Paroxysmal/therapyAbstract
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired genetic defect of the hematopoietic stem cell characterized by a triad of hemolytic anemia, pancytopenia, and thrombosis. Cutaneous thrombosis is a rare manifestation of this disease. Herein, we report a case of a patient with PNH whose first and only symptom was localized severe cutaneous thrombosis with hemorrhagic necrosis. During the diagnostic workup, it was necessary to exclude possible causes of chronic hemolysis without anemia and also to perform the confirmatory genetic test. The patient was discharged anticoagulated and with a recommendation for oral corticosteroids at weaning until initiating targeted therapy with eculizumab. To date, only 15 cases of PNH-associated cutaneous thrombosis have been documented worldwide. This paper focuses on highlighting and describing a rare manifestation of this disease and reviewing the existing literature.
Downloads
References
1. Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106:3699-709. doi: 10.1182/blood-2005-04-1717.
2. Hill A, DeZern A, Kinoshita T, Brodsky RA. Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers. 2017;3:17028. Doi:10.1038/nrdp.2017.28
3. Hillmen P, Muus P, Röth A, Elebute MO, Risitano AM, Schrezenmeier H, et al. Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2013;162:62-73. doi: 10.1111/bjh.12347.
4. Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2015;2015:CD004123. doi:10.1002/14651858.CD004123.pub4
5. Kelly RJ, Hill A, Arnold LM, Brooksbank GL, Richards SJ, Cullen M, et al. Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood. 2011;117:6786-92. doi: 10.1182/blood-2011-02-333997.
6. Röth A, Peffault de Latour R, Kulasekararaj A, Brodsky RA, Schrezenmeier H, Griffin M, et al. Long-term efficacy and safety of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria. Haematologica. 2020;105:e230–3. doi:10.3324/haematol.2019.236117
7. Hillmen P, Szer J, Weitz I, Röth A, Höchsmann B, Panse J, et al. Pegcetacoplan versus eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2021;384:1028–37. doi:10.1056/NEJMoa2029073.
8. Rietschel RL, Lewis CW, Simmons RA, Phyliky RL. Skin lesions in paroxysmal nocturnal haemoglobinuria. Arch Dermatol. 1978;114:560e3.
9. White JM, Watson K, Arya R, du Vivier AW. Haemorrhagic bullae in a case of paroxysmal nocturnal haemoglobinuria. Clin Exp Dermatol 2003;28:504e5.
10. Cholez C, Schmutz JL, Hulin C, Hesse JY, Barbaud A. Cutaneous necrosis during paroxysmal nocturnal haemoglobinuria: role of parvovirus B19? J Eur Acad Dermatol Venereol. 2005;19:381e2.
11. Alves J, Barreiros H, Matos D, Coelho R. Cutaneous thrombosis related to paroxysmal nocturnal hemoglobinuria: clinical report. Dermatol Online J. 2012;18:13.
12. Watt SG, Winhoven S, Hay CR, Lucas GS. Purpura fulminans in paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2007;137:271. doi: 10.1111/j.1365-2141.2007.06522.x.
13. Salim O, Yücel OK, Karatas G, Alan S, Bassorgun CI, Undar L. Cutaneous thrombosis as the presenting finding of paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2015;171:296. doi: 10.1111/bjh.13589.
14. Fu-Nien H, Tsai-Yun C Lee J. Severe cutaneous thrombosis with hemorrhagic necrosis in a patient with paroxysmal nocturnal hemoglobinuria: A case report and review of literature. Dermatol Sinica. 2017;35. Doi:10.1016/j.dsi.2017.01.006.
15. Rompoti N, Hillen U, Rösch A, Dissemond J. Purpura fulminans related to paroxysmal nocturnal haemoglobinuria. Eur J Dermatol. 2016;26:397-8. doi: 10.1684/ejd.2016.2786.
16. Otters EF, Zarafonitis G, Steenbergen EJ, van der Valk PG, Muus P. Rapidly evolving skin manifestations due to progressive thrombosis in a patient with paroxysmal nocturnal haemoglobinuria resolved with prompt initiation of eculizumab. Br J Dermatol. 2014;171:908-10. doi: 10.1111/bjd.13033.
17. Nagase K, Okawa T, Otsu M, Miura Y, Misago N, Narisawa Y. Extensive cutaneous ulcerations and necrosis associated with paroxysmal nocturnal hemoglobinuria. Arch Dermatol. 2012;148:660-2. doi: 10.1001/archdermatol.2011.3536.
18. Yamada T, Kurashige Y, Tokuyama M, Kawai M, Ota T, Ikoma N, et al. Zonal cutaneous ulceration and necrosis of the lower abdomen due to cutaneous thrombosis associated with paroxysmal nocturnal hemoglobinuria. J Dermatol. 2017;44:1073-4. doi: 10.1111/1346-8138.13646.
19. Martinez-Mera C, Montes-Torres A, Gordillo-Vélez C, Sánchez-Pérez J. Ecthyma Gangrenosum in Paroxysmal Nocturnal Hemoglobinuria. Acta Haematol. 2018;140:166-8. doi: 10.1159/000492739.
20. Otal V, Braccia V, Bertaina C, Gorosito M, Bussy R, Molteni A. Cutaneous thrombosis associated with paroxysmal nocturnal hemoglobinuria. Abstracts 24th World Congress of Dermatology Milan 2019.
21. Nara T, Kimori S, Nakamichi H, Ikeda Y, Akaogi T, Kurita M, et al. Extensive purpura in a patient with paroxysmal nocturnal hemoglobinuria. J Am Acad Dermatol. 2005;53:1090-2. doi: 10.1016/j.jaad.2005.07.049.
Downloads
Published
How to Cite
License
Copyright (c) 2025 Portuguese Journal Internal Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.



